Patents Assigned to Horizon Pharma AG
  • Patent number: 8920838
    Abstract: Provided are methods for the treatment of a rheumatic disease, such as rheumatoid arthritis, ankylosating spondylitis and/or polymyalgia rheumatic, by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks. Also provided are methods for the treatment of osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: December 30, 2014
    Assignee: Horizon Pharma AG
    Inventor: Achim Schaeffler
  • Publication number: 20140065214
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: April 10, 2013
    Publication date: March 6, 2014
    Applicant: Horizon Pharma AG
    Inventor: Horizon Pharma AG
  • Publication number: 20130190279
    Abstract: The present invention refers to the treatment of a patient suffering from rheumatoid arthritis by showing a reduction in signs and symptoms, a major or complete clinical response (remission) or even prevention of structural damages to the joints by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: March 8, 2013
    Publication date: July 25, 2013
    Applicant: Horizon Pharma AG
    Inventor: Horizon Pharma AG